Epidemiologic evidence indicates that diabetes is associated with increased risk of many types of cancer37; therefore, it is also possible that higher levels of EPO might contribute to the increased risk of mortality in diabetic patients because of an increased incidence of cancer. This evidence concerns the gene EPO and cancer.